Replies to post #87805 on Cytodyn Inc (CYDY)

[Blane]

I’m wondering if it has to do with residual RANTES levels. It will be interesting to see the full data from phase II mild/moderate. A patient may receive two doses one week apart and ‘recover’, but I wonder if any residual RANTES is left over still triggering subdued inflammatory processes in the body. Would be nice if Dr. P or someone else clarifies that.